JPWO2020229846A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020229846A5
JPWO2020229846A5 JP2021568646A JP2021568646A JPWO2020229846A5 JP WO2020229846 A5 JPWO2020229846 A5 JP WO2020229846A5 JP 2021568646 A JP2021568646 A JP 2021568646A JP 2021568646 A JP2021568646 A JP 2021568646A JP WO2020229846 A5 JPWO2020229846 A5 JP WO2020229846A5
Authority
JP
Japan
Prior art keywords
pharmaceutical formulation
omvs
formulation according
pharmaceutical
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021568646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022533976A (ja
Publication date
Priority claimed from GBGB1906830.3A external-priority patent/GB201906830D0/en
Application filed filed Critical
Publication of JP2022533976A publication Critical patent/JP2022533976A/ja
Publication of JPWO2020229846A5 publication Critical patent/JPWO2020229846A5/ja
Pending legal-status Critical Current

Links

JP2021568646A 2019-05-15 2020-05-15 バクテリア由来の外膜小胞の供給 Pending JP2022533976A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1906830.3 2019-05-15
GBGB1906830.3A GB201906830D0 (en) 2019-05-15 2019-05-15 Delivery of bacteria-derived outer membrane vesicles
PCT/GB2020/051204 WO2020229846A2 (en) 2019-05-15 2020-05-15 Delivery of Bacteria-Derived Outer Membrane Vesicles

Publications (2)

Publication Number Publication Date
JP2022533976A JP2022533976A (ja) 2022-07-27
JPWO2020229846A5 true JPWO2020229846A5 (enExample) 2023-03-30

Family

ID=67384734

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021568646A Pending JP2022533976A (ja) 2019-05-15 2020-05-15 バクテリア由来の外膜小胞の供給

Country Status (5)

Country Link
US (1) US20220175901A1 (enExample)
EP (1) EP3969042A2 (enExample)
JP (1) JP2022533976A (enExample)
GB (1) GB201906830D0 (enExample)
WO (1) WO2020229846A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114672507B (zh) * 2022-03-22 2024-04-16 浙江工业大学 一种可递呈多个异源肽或蛋白质的细菌外膜囊泡及其构建方法和应用
CN119875903B (zh) * 2025-01-13 2025-09-19 南昌大学 一种基于细菌外膜囊泡的抗生素载体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011127302A2 (en) * 2010-04-07 2011-10-13 Yue Shen Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
GB201607510D0 (en) * 2016-04-29 2016-06-15 Inst Of Food Res The Engineering gut commensal bacteria to express heterologous proteins in their outer membrane vesicles (OMV) for delivery to the GI-tract
GB201817194D0 (en) * 2018-10-22 2018-12-05 Quadram Inst Bioscience Gut bacteria derived microvesicles for vaccine delivery

Similar Documents

Publication Publication Date Title
US20230390381A1 (en) Immunogenic combinations
US5643577A (en) Oral vaccine comprising antigen surface-associated with red blood cells
TWI329130B (en) Functionally reconstituted viral membranes containing adjuvant
JP4137640B2 (ja) 新規プロテオソーム−リポサッカリドワクチンアジュバント
ES2307494T3 (es) Vacuna del virus de la gripe inactivo para su administracion via nasalu oral.
CN101212983B (zh) 包含α-半乳糖基神经酰胺作为佐剂的用于鼻内施用的疫苗组合物
US9603920B2 (en) Compositions and methods for treating influenza
HRP20140765T1 (hr) Vektori i konstrukti za prijenos antigena gripe
Kamphuis et al. Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats
JP2010537961A5 (enExample)
US20010026798A1 (en) Methods of enhancing activity of vaccines and vaccine compositions
CN112755180B (zh) 一种通用的细菌疫苗的制备方法和应用
RU2570394C2 (ru) Мукозальная вакцина
Pandey et al. Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B
JPWO2020229846A5 (enExample)
CN109069424A (zh) 脂质体疫苗
JPH05504756A (ja) 免疫刺激性を有する組成物と、そのヒトと獣医学用医薬への応用
Li et al. Study on the immunity protection of 14-3-3–MPLA–liposome vaccine against cystic echinococcosis in mice
CN101115503A (zh) 输送粘膜疫苗用的肽
CN102724998A (zh) 用于引发特异性免疫应答以治疗病毒感染和其他病症的具有肽佐剂的疫苗
US20130183340A1 (en) Intradermal influenza vaccine
US5985318A (en) Fusogenic liposomes that are free of active neuraminidase
CN115501333A (zh) 一种疫苗佐剂、疫苗组合物及其应用
WO2002062381A1 (en) Baculovirus vector vaccine
Gandhapudi et al. Recombinant Protein Vaccines Formulated with Enantio-Specific Cationic Lipid R-DOTAP Induce Protective Cellular and Antibody-Mediated Immune Responses in Mice., 2023, 15, 432